Back to Search
STEPHEN ZINNER, MD
MD
Infectious Disease Physician
NPI: 1629043245Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
30001(MA)
Research & Publications (20)
Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline.
PMID 18245198·J Antimicrob Chemother·2008
4-observational
Antibiotic pharmacodynamics and bacterial resistance: usefulness of in vitro models.
PMID 17430696·Curr Infect Dis Rep·2007
8-other
The search for new antimicrobials: why we need new options.
PMID 16307503·Expert Rev Anti Infect Ther·2005
6-review
Overview of antibiotic use and resistance: setting the stage for tigecycline.
PMID 16080067·Clin Infect Dis·2005
6-review
Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
PMID 15288317·Int J Antimicrob Agents·2004
4-observational
Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.
PMID 12951352·J Antimicrob Chemother·2003
8-other
Comparative anti-staphylococcal effects of gemifloxacin and trovafloxacin in an in vitro dynamic model in terms of AUC/MIC and dose relationships.
PMID 11576789·Diagn Microbiol Infect Dis·2001
8-other
The pharmacodynamics of gatifloxacin and ciprofloxacin for pneumococci in an in vitro dynamic model: prediction of equiefficient doses.
PMID 11733466·J Antimicrob Chemother·2001
4-observational
New pathogens in neutropenic patients with cancer: an update for the new millennium.
PMID 11053787·Int J Antimicrob Agents·2000
6-review
The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models.
PMID 19671586·J Antimicrob Chemother·2009
8-other
Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.
PMID 19095420·Int J Antimicrob Agents·2009
8-other
Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.
PMID 18635520·J Antimicrob Chemother·2008
4-observational
Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.
PMID 18790614·Int J Antimicrob Agents·2008
8-other
Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window.
PMID 18378704·Antimicrob Agents Chemother·2008
8-other
Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.
PMID 17207607·Int J Antimicrob Agents·2007
8-other
In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients.
PMID 16896825·Eur J Clin Microbiol Infect Dis·2006
8-other
Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
PMID 17028094·J Antimicrob Chemother·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 330 MOUNT AUBURN ST, SOUTH 2
CAMBRIDGE, MA 02138 - Phone
- (617) 499-5026
Quick Facts
- NPI
- 1629043245
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile